Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Incyte's JAK cream Opzelura slows while Leo competition looms
Leo Pharma's delgocitinib could shake up the topical JAK market and put pressure on Incyte's approved Opzelura.
Zoey Becker
May 3, 2024 10:53am
Sponsored
ADVI Experts Discuss the Future of the Inflation Reduction Act
Apr 29, 2024 8:00am
Merck's BCG monopoly could end
May 3, 2024 10:50am
Sponsored
Collaborative partnerships key to clearing the path for new biopharma products
Apr 29, 2024 8:00am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Marketing News
Lilly catches Indiana Fever with jersey, health equity collab
May 2, 2024 2:07pm
Dupixent COPD delay possible, Eylea down 2%, Regeneron says
May 2, 2024 12:00pm
Blood test maker Mirvie debuts preeclampsia prevention toolkit
May 2, 2024 11:49am
Moderna plots launch of its next potential mRNA vaccine approval
May 2, 2024 11:08am
See More Marketing News